{"id":41320,"date":"2017-03-23T06:43:38","date_gmt":"2017-03-23T05:43:38","guid":{"rendered":"https:\/\/rss.nova-institut.net\/public.php?url=http%3A%2F%2Fwww.euractiv.com%2Fsection%2Fhealth-consumers%2Fspecial_report%2Fbiomedicines-in-europe%2F"},"modified":"2017-03-17T15:08:27","modified_gmt":"2017-03-17T14:08:27","slug":"biomedicines-in-europe","status":"publish","type":"post","link":"https:\/\/renewable-carbon.eu\/news\/biomedicines-in-europe\/","title":{"rendered":"Biomedicines in Europe"},"content":{"rendered":"<p>Biotechnology could help patients across Europe gain access to innovative therapies, for example, against rare diseases. Proponents of bio-medicines also claim that precision therapy, because it is more efficient, will ease the burden on member states\u2019 ailing healthcare systems.<\/p>\n<p>Biotechnology is the use of living systems or organisms in the creation of industrial products. In Europe, it has created 10,000 new jobs and 93 medicines recommended for market authorisation by the European Medicines Agency in 2015.<\/p>\n<p>Despite consistent growth in the biotech sector, the European Biopharmaceutical Enterprises (EBE) association says the industry is not receiving enough support from investors, universities or research institutions, thus limiting Europe\u2019s ability to compete with the US.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Biotechnology could help patients across Europe gain access to innovative therapies, for example, against rare diseases. Proponents of bio-medicines also claim that precision therapy, because it is more efficient, will ease the burden on member states\u2019 ailing healthcare systems. Biotechnology is the use of living systems or organisms in the creation of industrial products. In [&#8230;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","nova_meta_subtitle":"","footnotes":""},"categories":[5572],"tags":[],"supplier":[13221,1904],"class_list":["post-41320","post","type-post","status-publish","format-standard","hentry","category-bio-based","supplier-european-biopharmaceutical-enterprises-ebe","supplier-eurepean-medicines-agency-emea"],"_links":{"self":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/posts\/41320","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/comments?post=41320"}],"version-history":[{"count":0,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/posts\/41320\/revisions"}],"wp:attachment":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/media?parent=41320"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/categories?post=41320"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/tags?post=41320"},{"taxonomy":"supplier","embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/supplier?post=41320"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}